KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calumet (CLMT) Cash & Equivalents (2022 - 2025)

Historic Cash & Equivalents for Calumet (CLMT) over the last 4 years, with Q3 2025 value amounting to $94.6 million.

  • Calumet's Cash & Equivalents rose 17341.04% to $94.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.6 million, marking a year-over-year increase of 17341.04%. This contributed to the annual value of $38.1 million for FY2024, which is 38227.85% up from last year.
  • Calumet's Cash & Equivalents amounted to $94.6 million in Q3 2025, which was up 17341.04% from $110.6 million recorded in Q2 2025.
  • Over the past 5 years, Calumet's Cash & Equivalents peaked at $123.4 million during Q1 2025, and registered a low of $7.0 million during Q2 2024.
  • In the last 4 years, Calumet's Cash & Equivalents had a median value of $35.2 million in 2022 and averaged $48.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 8356.81% in 2024, then surged by 148000.0% in 2025.
  • Over the past 4 years, Calumet's Cash & Equivalents (Quarter) stood at $35.2 million in 2022, then crashed by 77.56% to $7.9 million in 2023, then surged by 382.28% to $38.1 million in 2024, then surged by 148.29% to $94.6 million in 2025.
  • Its last three reported values are $94.6 million in Q3 2025, $110.6 million for Q2 2025, and $123.4 million during Q1 2025.